Back

Cardiovascular toxicity of fluoropyrimidines

19 June 2026 (13:05 - 13:20)
Organised by: Logo
Congress Presentation Part of: Cardiovascular toxicity of fluoropyrimidines: Clinical challenges and emerging management strategies Cardiovascular Toxicity of Cancer Therapies Open Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Alexander Lyon

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor A. Lyon (London, GB)
Presentation thumbnail
Development of S-1 in metastatic colorectal cancer (mCRC)
Professor C. Punt (Utrecht, NL)
Slides
Presentation thumbnail
From science to clinical practice: treatment options following cardiovascular toxicity
Doctor I. Fabiani (Pisa, IT)
Slides
Presentation thumbnail
Discussion and Q&A
Slides

Access the full session

Session thumbnail
Cardiovascular toxicity of fluoropyrimidines: Clinical challenges and emerging management strategies
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 13:05 CET
You may be interested in
thumbnail
Congress Presentation
Severe cardiotoxicity due to fluoropyrimidines and the rol of the cardio-oncology team
31 August 2025
thumbnail
Congress Presentation
Cardiovascular toxicities reported with Poly ADP Ribose Polymerase (PARP) inhibitors in the FDA Adverse Event Reporting System
21 June 2025
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Webinar
How to organise cardiovascular monitoring during cancer treatment: who, when and how. ESC 2022 Clinical Practice Guidelines - Webinar Series
26 September 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources